Column A Column B ___a. minor histocompatibility antigens 1. allotypic differenc
ID: 81183 • Letter: C
Question
Column A
Column B
___a. minor histocompatibility antigens
1. allotypic differences that arise from polymorphisms in human proteins
___b. haploidentical transplant
2. on the surface of hematopoietic stem cells
___c. autologous hematopoietic cell transplantation
3. only one HLA haplotype is shared but not both
___d. graft-versus-tumor effect
4. removal of harmful cells from one’s own bone marrow before reinfusion
___e. CD34
5. residual leukemic cells eliminated by alloreactive T cells or NK cells in a graft.
Column A
Column B
___a. minor histocompatibility antigens
1. allotypic differences that arise from polymorphisms in human proteins
___b. haploidentical transplant
2. on the surface of hematopoietic stem cells
___c. autologous hematopoietic cell transplantation
3. only one HLA haplotype is shared but not both
___d. graft-versus-tumor effect
4. removal of harmful cells from one’s own bone marrow before reinfusion
___e. CD34
5. residual leukemic cells eliminated by alloreactive T cells or NK cells in a graft.
Explanation / Answer
Answer:
Column A
Column B
___a. minor histocompatibility antigens
1. allotypic differences that arise from polymorphisms in human proteins
___b. haploidentical transplant
3. only one HLA haplotype is shared but not both
___c. autologous hematopoietic cell transplantation
4. removal of harmful cells from one’s own bone marrow before reinfusion
___d. graft-versus-tumor effect
5. residual leukemic cells eliminated by alloreactive T cells or NK cells in a graft.
___e. CD34
2. on the surface of hematopoietic stem cells
Column A
Column B
___a. minor histocompatibility antigens
1. allotypic differences that arise from polymorphisms in human proteins
___b. haploidentical transplant
3. only one HLA haplotype is shared but not both
___c. autologous hematopoietic cell transplantation
4. removal of harmful cells from one’s own bone marrow before reinfusion
___d. graft-versus-tumor effect
5. residual leukemic cells eliminated by alloreactive T cells or NK cells in a graft.
___e. CD34
2. on the surface of hematopoietic stem cells